eISSN: None / ISSN: 1673-5269
Register
Login
Volume 30 Issue 7 (2023): None
Articles
Research progress of radiotherapy combined with PD-1/PD-L1 inhibitors in advanced breast cancer; 晚期乳腺癌放疗联合 PD-1/PD-L1 抑制剂治疗研究进展
C. Li, 
Q. Liu, 
T. Wang, 
T. Tian, 
X. Liu, 
M. Zhang
436-442
Research progress of PD-1/PD-L1 inhibitors in advanced NSCLC patients after failure of EGFR-TKls therapy; 晚期 NSCLC EGFR-TKIs 治疗失败 应用PD-1/PD-L1 抑制剂进展
C. Wang, 
J. Yin, 
Q. Guo
430-435
Comparison of the clinical effect of volumetric modulated arc therapy and intensity modulated radiotion therapy in treating middle-and advanced-stage cervical carcinoma; 中晚期宫颈癌治疗中容积旋转调强与固定野调强临床疗效比较
F. Ding, 
S. Zhang, 
D. Liu, 
X. Li, 
F. Wang, 
P. Xu, 
J. Li
424-429
Risk factors of the malignant transformation of ovarian endometriosis; 卵巢型子宫内膜异位症恶变危险因素初步分析
F. Chen, 
X. Liu, 
X. Liu
419-423
Effects of rotational setup errors on dose distribution of radiotherapy after breast conserving surgery for breast cancer; 旋转摆位误差对乳腺癌保留乳房术后放疗剂量分布的影响
M. Fu, 
Y. Cui, 
J. Chen, 
C. Tao, 
W. Qiu, 
J. Zhu
412-418
Efficacy evaluation and prognostic factors analysis of PD-1 inhibitor combined with chemotherapy in advanced esophageal squamous cell carcinoma; PD-1抑制剂联合化疗治疗晚期食管鳞状细胞癌的疗效评估及预后分析
S. Liu, 
H. Miao, 
Y. Wang, 
N. Xie, 
F. Tong, 
G. Liu
406-411
Effect of SEMA5A on cell proliferation and apoptosis of hepatocellular carcinoma and possible mechanism; SEMA5A对肝细胞癌增殖及凋亡的影响及可能机制
Y. Wang, 
S. Zhang, 
J. Zhang, 
Q. Jin
397-405
Targeting imaging and tumor inhibition of 177Lu-FA-DOTA-PEG-PLGA long circulating nanoparticles; 177Lu-FA-DOTA-PEG-PLGA 长循环纳米粒子靶向显像和抑瘤实验
J. Zhao, 
M. Zhao, 
Z. Guo, 
J. Wang, 
C. Pan
392-396
Survey on the cognitive situation of cervical cancer and HPV vaccine among women in Tibet; 西藏地区女性对宫颈癌及犎犘犞疫苗认知调查
W. Xie, 
L. Liu, 
L. Shao, 
Y. Feng, 
Z. Dan, 
R. Ci, 
Y. Huang, 
X. Guo, 
M. Yang
386-391
Guidelines for the prevention and treatment of acute mucositis associated with radiation therapy for head and neck tumors (2023 updated version); 头颈部肿瘤放射治疗相关急性黏膜炎的预防与治疗指南(2023年更新版)
381-385
Submit Article Peer Review Policy Advertising Policy Aim and Scope Author Guidelines Authorship and contributorship Complaints and Appeals Conflicts of Interest Copyright Transfer Agreement (CTA) Copyright and Publishing Rights Data Sharing Policy Guide for Reviewers Open Access Policy Preservation Policy Research and Publication Ethics Direct Marketing Manuscript Submission Generative AI Policy Indexing Guide for Editor Editorial Policies Human and Animal Rights Authorship and Contributorship Informed Consent Policy Data Sharing Policy Content Licensing Quality Control System Policy of Screening for Plagiarism Process Policy of Dealing with Allegations of Research Misconduct Corrections and Retractions Complaints and Appeals Contact Us
Indexations
Visits in the last year
View statistics

For any inquiries regarding the journal, publication process, or manuscript status, please contact the Editorial Office at support@cjcpt.org.

 

Authors are requested to submit their manuscripts and related documents via email at submission@cjcpt.org

 

Address: Jinan, Shandong Province, Ji Yan Road #440 - Location

 

Please contact us on WhatsApp: https://wa.me/447460013985 

Open Access Publication
Advertising Policy